Fumafer

Role

Indications

Reactions

Secondary

Product Used For Unknown Indication	63.1%
Foetal Exposure During Pregnancy	10.7%
Maternal Exposure Timing Unspecified	10.7%
Nausea	1.8%
Urinary Tract Infection	1.6%
Breast Cancer	1.3%
Drug Use For Unknown Indication	1.3%
Parenteral Nutrition	1.3%
Prophylaxis	1.3%
Induction Of Anaesthesia	1.0%
Anxiety	0.8%
Maternal Exposure Before Pregnancy	0.8%
Bacterial Infection	0.5%
Calcium Deficiency	0.5%
Depression	0.5%
Device Related Infection	0.5%
Dyslipidaemia	0.5%
Foetal Growth Restriction	0.5%
Hypertension	0.5%
Hyperthermia	0.5%

Premature Baby	16.7%
Foetal Growth Restriction	11.9%
Maternal Exposure Timing Unspecified	9.5%
Skin Exfoliation	9.5%
Neutrophil Count Decreased	4.8%
Pulmonary Embolism	4.8%
Rash Maculo-papular	4.8%
Somnolence	4.8%
Thrombocytopenia	4.8%
Vomiting	4.8%
Bicytopenia	2.4%
Maternal Drugs Affecting Foetus	2.4%
Pregnancy	2.4%
Premature Labour	2.4%
Pulmonary Infarction	2.4%
Rhabdomyolysis	2.4%
Staphylococcal Infection	2.4%
Toxic Skin Eruption	2.4%
Urosepsis	2.4%
Weight Decreased	2.4%

Concomitant

Drug Use For Unknown Indication	33.6%
Product Used For Unknown Indication	18.3%
Hypertension	9.6%
Pain	5.0%
Thrombosis Prophylaxis	4.3%
Iron Deficiency	3.4%
Type 2 Diabetes Mellitus	2.8%
Hypercholesterolaemia	2.5%
Renal Failure Chronic	2.5%
Depression	2.1%
Hiv Infection	2.1%
Anaemia	2.0%
Rheumatoid Arthritis	2.0%
Asthma	1.6%
Atrial Fibrillation	1.6%
Diabetes Mellitus	1.4%
Pulmonary Tuberculosis	1.4%
Cardiac Failure	1.2%
Chronic Lymphocytic Leukaemia	1.2%
Iron Deficiency Anaemia	1.2%

Pregnancy	9.6%
Malaise	8.5%
Renal Failure Acute	8.5%
Sepsis	7.4%
Thrombocytopenia	7.4%
Drug Ineffective	5.3%
Neutropenia	5.3%
Deep Vein Thrombosis	4.3%
General Physical Health Deterioration	4.3%
Oesophageal Pain	4.3%
Paralysis	4.3%
Staphylococcal Infection	4.3%
Ultrasound Antenatal Screen Abnormal	4.3%
International Normalised Ratio Increased	3.2%
Off Label Use	3.2%
Pancytopenia	3.2%
Pharyngolaryngeal Pain	3.2%
Rectal Haemorrhage	3.2%
Respiratory Distress	3.2%
Somnolence	3.2%